Sector ratings Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE 16:00:02 2026-09-10 EDT			5-day change	1st Jan Change
273.00 ^USD	-1.92%		-6.94%	+36.86%

09-08	Charles River Laboratories International Implements Endosafe Cartridge Technology Automated Manufacturing Suite	CI
08-20	Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	13.03B		AA
LONZA GROUP AG	46.05B		AAA
REVOLUTION MEDICINES, INC.	43.59B	-	B	-	-
IQVIA HOLDINGS INC.	42.35B		AAA
BEONE MEDICINES AG	38.86B		-
CELLTRION, INC.	32.24B		A
ASCENDIS PHARMA A/S	17.16B	-	-	-	-
MEDPACE HOLDINGS, INC.	16.28B		BBB
EUROFINS SCIENTIFIC SE	14.32B		AA
ICON PUBLIC LIMITED COMPANY	12.78B		AAA
BIO-TECHNE CORPORATION	11.3B		AA
TEMPUS AI, INC.	10.6B		A		-
PHARMARON BEIJING CO., LTD.	10.44B		AA
ABIVAX	10.17B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	9.45B	-	B	-	-
KYMERA THERAPEUTICS, INC.	9.73B	-	BBB	-	-
GENSCRIPT BIOTECH CORPORATION	8.92B		AA		-
PROTAGONIST THERAPEUTICS, INC.	9.39B		BB		-
IONIS PHARMACEUTICALS, INC.	9.25B	-	A	-	-
QIAGEN N.V.	8.71B		AAA
Average	18.73B		AA
Weighted average by Cap.			AA